November 13, 2026 · Industry Insights Retatrutide Cuts Knee Pain in Obesity OA Trials, NEJM Reports Two NEJM-published trials found retatrutide sharply reduced knee pain in obese adults with osteoarthritis, a signal for the GLP-1 peptide sector and its supply chain. Read article →